Showing results (1-10 of 803) with videos related to
Sort By:
Pageof 81
Future Oncology (London, England)|July 19, 2021
Neoadjuvant osimertinib with/without chemotherapy versus chemotherapy alone for EGFR-mutated resectable non-small-cell lung cancer: NeoADAURAMasahiro Tsuboi, Walter Weder, Carles Escriu, et al.Nature Reviews. Clinical Oncology|April 29, 2021
Evolution of systemic therapy for stages I-III non-metastatic non-small-cell lung cancerJamie E Chaft, Andreas Rimner, Walter Weder, et al.Lung Cancer (Amsterdam, Netherlands)|February 3, 2023
Primary endpoints to assess the efficacy of novel therapeutic approaches in epidermal growth factor receptor-mutated, surgically resectable non-small cell lung cancer: A reviewCollin M Blakely, Walter Weder, Lukas Bubendorf, et al.Journal of Thoracic Disease|March 30, 2018
Immunotherapy in surgically resectable non-small cell lung cancerDwight Owen, Jamie E ChaftAnnals of Translational Medicine|August 30, 2016
Have adjuvant tyrosine kinase inhibitors lost their shine?Joshua K Sabari, Jamie E ChaftTranslational Lung Cancer Research|March 10, 2023
Early-stage anaplastic lymphoma kinase (ALK)-positive lung cancer: a narrative reviewMonica F Chen, Jamie E ChaftLymphatic Research and Biology|December 31, 2004
Genetics of vascular anomalies: an updateJamie E Chaft, David A Steckman, Francine BleiAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 24, 2024
Moving Immunotherapy Into the Treatment of Resectable Non-Small Cell Lung CancerJamie E Chaft, Rafal Dziadziuszko, Bernardo Haddock Lobo GoulartAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Chemotherapy for lung cancers: here to stayMark G Kris, Matthew D Hellmann, Jamie E ChaftNihon Geka Gakkai Zasshi|June 21, 2014
[Current status of postoperative adjuvant chemotherapy for completely resected non-small lung cancer]Masahiro TsuboiPageof 81